These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
220 related items for PubMed ID: 9792572
1. Effects of cysteinyl-leukotriene receptor antagonist, thromboxane A2 receptor antagonist, and thromboxane A2 synthetase inhibitor on antigen-induced bronchoconstriction in patients with asthma. Obase Y, Shimoda T, Matsuo N, Matsuse H, Asai S, Kohno S. Chest; 1998 Oct; 114(4):1028-32. PubMed ID: 9792572 [Abstract] [Full Text] [Related]
6. Can urinary eicosanoids be a potential predictive marker of clinical response to thromboxane A2 receptor antagonist in asthmatic patients? Tanaka H, Igarashi T, Saitoh T, Teramoto S, Miyazaki N, Kaneko S, Ohmichi M, Abe S. Respir Med; 1999 Dec; 93(12):891-7. PubMed ID: 10653051 [Abstract] [Full Text] [Related]
7. Effect of a selective thromboxane A2 receptor antagonist BAY u3405 on antigen-, leukotriene C4- and leukotriene D4-induced bronchoconstriction in guinea pigs. Iwamoto I, Umibe T, Nakajima H, Yoshida S. Int Arch Allergy Immunol; 1995 Sep; 108(1):68-73. PubMed ID: 7647588 [Abstract] [Full Text] [Related]
10. Thromboxane A2 inhibition: therapeutic potential in bronchial asthma. Dogné JM, de Leval X, Benoit P, Delarge J, Masereel B. Am J Respir Med; 2002 Sep; 1(1):11-7. PubMed ID: 14720071 [Abstract] [Full Text] [Related]
11. Long-term observations of the clinical course after step down of corticosteroid inhalation therapy in adult chronic asthmatics: correlation with serum levels of eosinophil cationic protein. Baba K, Sakakibara A, Yagi T, Niwa S, Wakayama H, Takagi K. Respirology; 2002 Sep; 7(3):255-66. PubMed ID: 12153692 [Abstract] [Full Text] [Related]
12. Effect of leukotriene and thromboxane antagonist on propranolol-induced bronchoconstriction. Fujimura M, Abo M, Kamio Y, Myou S, Ishiura Y, Hashimoto T, Matsuda T. Am J Respir Crit Care Med; 1999 Dec; 160(6):2100-3. PubMed ID: 10588635 [Abstract] [Full Text] [Related]
16. Effects of KP-496, a novel dual antagonist at the cysteinyl leukotriene receptor 1 and the thromboxane A(2) receptor, on airway obstruction in guinea pigs. Ishimura M, Suda M, Morizumi K, Kataoka S, Maeda T, Kurokawa S, Hiyama Y. Br J Pharmacol; 2008 Feb; 153(4):669-75. PubMed ID: 18037905 [Abstract] [Full Text] [Related]
17. Effects of Y-24180, a long-acting and potent antagonist to platelet-activating factor, on immediate asthmatic response in guinea pigs. Kagoshima M, Tomomatsu N, Iwahisa Y, Yamaguchi S, Kawakami Y, Terasawa M. Pharmacology; 1997 Jan; 54(1):1-7. PubMed ID: 9065955 [Abstract] [Full Text] [Related]
18. Effect of pranlukast on bronchial inflammation in patients with asthma. Yoshida S, Ishizaki Y, Shoji T, Onuma K, Nakagawa H, Nakabayashi M, Akahori K, Hasegawa H, Amayasu H. Clin Exp Allergy; 2000 Jul; 30(7):1008-14. PubMed ID: 10848924 [Abstract] [Full Text] [Related]
19. Thromboxane antagonism and cough in chronic bronchitis. Ishiura Y, Fujimura M, Yamamori C, Nobata K, Myou S, Kurashima K, Takegoshi T. Ann Med; 2003 Jul; 35(2):135-9. PubMed ID: 12795341 [Abstract] [Full Text] [Related]
20. [Correlation between the clinical effects of Seratrodast and the level of 11-dehydrothromboxane B2 in urine/sputum in bronchial asthma patients]. Muramatsu H, Kotajima R, Sato T. Arerugi; 2001 Jun; 50(6):540-6. PubMed ID: 11517517 [Abstract] [Full Text] [Related] Page: [Next] [New Search]